Immucell, an animal health focused company in Portland is planning an expansion, Mainebiz reports. The manufacturer of Mast Out, a drug that treats mastitis in cows, will build a new facility on the land behind its current location in Portland. The company is also planning additional FDA approvals to bring the animal treatment to the commercial market. Read full story here
Immucell Building a New Facility Later This Year
Related Posts
Bangor will be abuzz with Maine science at annual festival
The Maine Science Festival’s headlining event will be a major collaboration with a local arts organization for the second year in...
Report: National Institutes of Health added $264M to Maine economy in 2022
The National Institutes of Health supported 1,950 jobs and $264 million in economic activity in Maine during 2022 through $112.7 million in grants and...
Northern Light completes deal to outsource diagnostics to Quest
Quest Diagnostics (NYSE: DGX), a Secaucus, N.J.-based diagnostic information services provider with a national footprint, said Monday that it has completed the acquisition...